Survey: Pharmacist & nurse perceptions of the management of cancer patient sexual well-being

We are undertaking a survey to review sexual well-being views and practices of specialist nurses and pharmacists caring for haemato-oncology patients. Please can we emphasise we are not referring to fertility in this context.

Sexual health is defined as a “state of physical, emotional, mental and social well-being in relation to sexuality; it is not merely the absence of disease, dysfunction or infirmity”.

A cancer diagnosis and starting cancer treatment, including systemic anti-cancer therapy treatment side effects can have a huge impact on patient sexual well-being. 

We would be grateful if you could complete the short survey below. Survey should not take more then 10 minutes to complete.

 

Link to survey: https://forms.office.com/Pages/ResponsePage.aspx?id=slTDN7CF9UeyIge0jXdO47zw8DeHc4lHi82EjtfPgutUMTdDRUcwR0I1TVJHRlo3M1BGM0ozVkhPVS4u

 

Sent on behalf of
Chiara Creed & Clare Geoghegan
University College London Hospitals NHS Foundation Trust

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article